Phibro Animal Health Inc. (PAHC) Price to Earnings Ratio

Phibro Animal Health Corp - graphic logo of issuer PAHC

The consolidated P/E of Phibro Animal Health (PAHC) reflects the business valuation trend, where 7.30 determines the current value of the metric. Phibro Animal Health is implementing eco-friendly additives to reduce methane and wastewater treatment. The modernization of bioreactors ensures high capacity utilization. Complex drug formulas and strict government safety oversight create a high barrier to entry.

PAHC: Phibro Animal Health Price to Earnings Ratio 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Phibro (PAHC)

- price and consensus price forecast:
Stock Price pahc.com|PAHC - Price Target Chart
- market capitalization details:
Market Value Phibro Animal Health Corporation|PAHC - Real Price to Acquire Entire Company
- book capitalization information:
Book Price of a Share Phibro Animal Health|PAHC - Company Net Assets|Market Capitalization to Book Value Ratio pahc.com|PAHC - Aggregate Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Phibro Animal Health|PAHC - Long-Term Debt to Capital|Short-Term Debt to Capital Phibro Animal Health Inc.|PAHC - Company Debts|Debt to Book Capitalization Ratio Phibro Animal Health Corporation|PAHC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Phibro Animal Health|Intermediate Coverage Ratio pahc.com
- earnings and valuation multiples information:
PAHC - Net Profit|Expected Net Profit Phibro Animal Health|PAHC - Price to Earnings Ratio|Market Cap to Projected Earnings Phibro Animal Health Corp|PAHC - Price/Earnings to Growth Ratio|Company Value to EBITDA Phibro Animal Health Corporation|PAHC - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Phibro Animal Health|PAHC - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months pahc.com|PAHC - Earnings growth in current year|Expected earnings per share growth for next year Phibro Animal Health
Comprehensive company analysis:pahc.com
Flagship merchandise of Phibro

A stable workforce and the retention of key biologists provide Phibro Animal Health (PAHC) with operational resilience, which is reflected in the company's P/E ratio chart. This indicator relates market capitalization to net income, allowing investors to assess the investment payback period and market expectations regarding cash flow gap risks, thereby confirming the business's fundamental value during periods of volatility.

Competing companies

P/E Multiple corteva.com|Price to Earnings Ratio Nutrien (NTR)|Price to Earnings Ratio CF (CF Industries Holdings, Inc.)|Mosaic Corp - Price to Earnings Ratio|Market Price to Net Income Ratio ELAN (Elanco Corp)|BCPC: Price to Earnings Ratio|FMC - P/E Multiple|Scotts (SMG) - Price to Earnings Ratio|CVR Partners LP - Company Value to Net Income|ODC (Oil-Dri Corporation) - P/E Multiple|P/E Multiple Intrepid Corp|Price to Earnings Ratio Lavoro Limited (LVRO)|Price to Earnings Ratio AVD (american-vanguard.com)|Brazil Potash - Price to Earnings Ratio|Company Value to Net Income ICCC|ENFY - Price to Earnings Ratio|Company Value to Net Income SEED (Origin Agritech Limited)|CGA: P/E Multiple|Market Cap to Earnings swseedco.com (SANW)